Cancer chemotherapy and pharmacology
Prediction of CYP3A4-mediated drug-drug interactions of a novel Bcl-2 inhibitor TQB3909 using physiologically based pharmacokinetic modeling.
Hui Chen, Shixing Zhu, Anqi Yang, Xu Li, Xunqiang Wang, Wei Zhao, Xin Wang, Ding Yu
Published: 202510.1007/s00280-025-04838-w
No abstract available for this study.